- cafead   Jan 04, 2023 at 05:42: PM
via Prevail Therapeutics, the gene therapy-focused subsidiary of Eli Lilly announced a partnership with biotechnology company Capsida Biotherapeutics to develop genetic medicines for central nervous system diseases.
article source
article source